Here, we identified a novel ER-NFĸB-driven stem-like population derived from ER+ breast cancer cell lines grown as MS, and demonstrate that this population is clinically relevant as its gene signature is expressed in aggressive breast cancer phenotypes and is predictive of tumor relapse. The gene discussed is ESR1; the disease is breast cancer.